National Stock Number
6505-00-279-7606
National Stock Number (NSN) 6505-00-279-7606, or NIIN 002797606, (prednisone tablets) was assigned August 12, 1973 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.
There are 8 manufacturer part numbers associated with this NSN. 3 of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 8 suppliers. Today, 5 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 5 suppliers are deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over 5 years, with the most recent procurement date of Jul 11, 2014. There have been 2 contracts issued for this part number, with 2 awards given. There is minimal competition for this NSN. The US Government has awarded contracts to 2 different suppliers. The last contract numbers awarded were: SPE2DP13D0925, SPM20007A1058. The total value of the awarded contracts has been US$ 58.65.
Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 02, 2006, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.
This NSN is assigned to Item Name Code (INC) 09569. []. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505002797606 does not contain precious metals.
This NSN is associated to Schedule B 2937210000: cortisone, hydrocortisone, prednisone and prednisolone. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325411: medicinal and botanical manufacturing.
This information was last updated on Apr 01, 2024.